SISRAM MED (01696) Signs Letter of Cooperation Intent with X-Medical, Plans Localized Production in China

Stock News

Jan 21

SISRAM MED (01696) announced that the company entered into a letter of cooperation intent with X-Medical Technology (Beijing) Co., Ltd. in January 2026, establishing a strategic cooperation framework for potential localized collaboration in China. According to the letter of intent, the potential cooperation aims to establish localized production in China, one of the Group's core strategic markets, with a focus on the deployment of energy-based medical aesthetic equipment. This move is a significant step in implementing the company's strategy to deepen its customer-centric core approach by effectively shortening the supply chain and enhancing responsiveness to the local market. The initiative is designed not only to meet domestic demand but also to build a regional cornerstone for the Asia-Pacific strategic hub, catering to the growing needs across the region for scaled mass production, efficient logistics systems, and advanced technology.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1120629159"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120629159\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120629159?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-21 17:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120629159","market":"hk","top_or_hot":-1,"title":"SISRAM MED (01696) Signs Letter of Cooperation Intent with X-Medical, Plans Localized Production in China","media":"Stock News","content":"<p>SISRAM MED (01696) announced that the company entered into a letter of cooperation intent with X-Medical Technology (Beijing) Co., Ltd. in January 2026, establishing a strategic cooperation framework for potential localized collaboration in China. According to the letter of intent, the potential cooperation aims to establish localized production in China, one of the Group's core strategic markets, with a focus on the deployment of energy-based medical aesthetic equipment. This move is a significant step in implementing the company's strategy to deepen its customer-centric core approach by effectively shortening the supply chain and enhancing responsiveness to the local market. The initiative is designed not only to meet domestic demand but also to build a regional cornerstone for the Asia-Pacific strategic hub, catering to the growing needs across the region for scaled mass production, efficient logistics systems, and advanced technology.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SISRAM MED (01696) Signs Letter of Cooperation Intent with X-Medical, Plans Localized Production in China</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSISRAM MED (01696) Signs Letter of Cooperation Intent with X-Medical, Plans Localized Production in China\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-01-21 17:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SISRAM MED (01696) announced that the company entered into a letter of cooperation intent with X-Medical Technology (Beijing) Co., Ltd. in January 2026, establishing a strategic cooperation framework for potential localized collaboration in China. According to the letter of intent, the potential cooperation aims to establish localized production in China, one of the Group's core strategic markets, with a focus on the deployment of energy-based medical aesthetic equipment. This move is a significant step in implementing the company's strategy to deepen its customer-centric core approach by effectively shortening the supply chain and enhancing responsiveness to the local market. The initiative is designed not only to meet domestic demand but also to build a regional cornerstone for the Asia-Pacific strategic hub, catering to the growing needs across the region for scaled mass production, efficient logistics systems, and advanced technology.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1585","symbol_name":"昨日强势股","start_time":0,"source_url":"","article_id":"1120629159","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120629159","pubTimestamp":1768987219,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"SISRAM MED (01696) announced that the company entered into a letter of cooperation intent with X-Medical Technology (Beijing) Co., Ltd. in January 2026, establishing a strategic cooperation framework...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159891":"医疗","BK1585":"昨日强势股","BK1100":"医疗保健设备","01696":"复锐医疗科技","BK1593":"医美概念股"},"translate_title":"SISRAM MED(01696)与X-Medical签署合作意向书，计划在中国本地化生产","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159891":1,"01696":1},"content_text":"SISRAM MED (01696) announced that the company entered into a letter of cooperation intent with X-Medical Technology (Beijing) Co., Ltd. in January 2026, establishing a strategic cooperation framework for potential localized collaboration in China. According to the letter of intent, the potential cooperation aims to establish localized production in China, one of the Group's core strategic markets, with a focus on the deployment of energy-based medical aesthetic equipment. This move is a significant step in implementing the company's strategy to deepen its customer-centric core approach by effectively shortening the supply chain and enhancing responsiveness to the local market. The initiative is designed not only to meet domestic demand but also to build a regional cornerstone for the Asia-Pacific strategic hub, catering to the growing needs across the region for scaled mass production, efficient logistics systems, and advanced technology.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}